TargetRx Atlas

mRNA_ID Gene Name drug_ID drug_Name Disease RNA_exp_pattern Evidence Details
ENST00000358813 CCL20 NA NA endometrial cancer up-regulated predicted more...
ENST00000358813 CCL20 NA NA ovarian cancer up-regulated predicted more...
ENST00000358813 CCL20 NA NA laryngeal cancer up-regulated predicted more...
ENST00000358813 CCL20 NA NA thyroid cancer up-regulated predicted more...
ENST00000358813 CCL20 NA NA ovarian cancer up-regulated predicted more...
ENST00000358813 CCL20 NA NA glioma up-regulated predicted more...
ENST00000358813 CCL20 NA NA lung adenocarcinoma up-regulated predicted more...
ENST00000358813 CCL20 DB08868 Fingolimod multiple sclerosis down-regulated validated more...
ENST00000358813 CCL20 DB17060 U-0126 chronic obstructive pulmonary disease down-regulated validated more...
ENST00000358813 CCL20 NA HSP90 inhibitor RGRN-305 psoriasis down-regulated validated more...
ENST00000358813 CCL20 NA salidroside ventricular arrhythmia down-regulated validated more...
@Copyright Harbin Medical University
　The 2nd Affiliated Hospital of Harbin Medical University
　 备案号：鲁ICP备2022025566号-3